Clinical Trial Update: Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the efficacy and safety of sodium-glucose cotransporter-2 inhibitors in adolescents with early-stage chronic kidney di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Centenario Hospital Miguel Hidalgo | Conditions: Chronic Kidney Disease (Mild to Moderate), Albuminuria | Phase 4 | Status: NOT_YET_RECRUITING